{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:26Z","timestamp":1787010026684,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/ico.0b013e31828ffdf8","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T12:48:52Z","timestamp":1368622132000},"page":"1149-1154","source":"Crossref","is-referenced-by-count":41,"title":["Tear Cytokine Levels in Vernal Keratoconjunctivitis"],"prefix":"10.1097","volume":"32","author":[{"given":"Merih","family":"Oray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Toker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210204","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","article-title":"Vernal keratoconjunctivitis: pathogenesis and treatment.","volume":"21","author":"Leonardi","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"R2-17-20210204","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1755-3768.2008.01347.x","article-title":"Vernal keratoconjunctivitis: a major review.","volume":"87","author":"Kumar","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"R3-17-20210204","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00130832-200110000-00015","article-title":"Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies.","volume":"1","author":"Solomon","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R4-17-20210204","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000310733","article-title":". Interleukin-4 and IgE in seasonal allergic conjunctivitis.","volume":"210","author":"Fujishima","year":"1996","journal-title":"Ophthalmologica"},{"key":"R5-17-20210204","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1046\/j.1365-2222.2000.00974.x","article-title":"Conjunctival cytokines in ocular allergy.","volume":"30","author":"McGill","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"R6-17-20210204","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/bjo.82.10.1203","article-title":". Allergic eye disease mechanisms.","volume":"82","author":"McGill","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"R7-17-20210204","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses.","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R8-17-20210204","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":". A randomized trial of topical cyclosporin 0.05 in topical steroid-resistant atopic keratoconjunctivitis.","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"R9-17-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-1759(01)00407-0","article-title":"Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics.","volume":"254","author":"Cook","year":"2001","journal-title":"J Immunol Methods"},{"key":"R10-17-20210204","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0002-9394(86)90819-6","article-title":". Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis.","volume":"101","author":"BenEzra","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"R11-17-20210204","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis.","volume":"110","author":"Secchi","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"R12-17-20210204","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(91)32069-4","article-title":"Topical cyclosporine in vernal keratoconjunctivitis.","volume":"98","author":"Bleik","year":"1991","journal-title":"Ophthalmology"},{"key":"R13-17-20210204","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","article-title":". Efficacy of 1.25 and 1 topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.","volume":"17","author":"Spadavecchia","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"R14-17-20210204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/eye.2001.10","article-title":"Topical cyclosporin A in the management of vernal keratoconjunctivitis.","volume":"15","author":"Gupta","year":"2001","journal-title":"Eye (Lond)"},{"key":"R15-17-20210204","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","article-title":". Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.","volume":"89","author":"Pucci","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R16-17-20210204","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/ICO.0b013e31812dfab3","article-title":"Management of severe allergic conjunctivitis with topical cyclosporin A 0.05 eyedrops.","volume":"26","author":"Ozcan","year":"2007","journal-title":"Cornea"},{"key":"R17-17-20210204","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00130832-200410000-00018","article-title":"Tear cytokines in acute and chronic ocular allergic inflammation.","volume":"4","author":"Cook","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R18-17-20210204","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1365-2222.2006.02499.x","article-title":". Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures.","volume":"36","author":"Leonardi","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"R19-17-20210204","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2222.2004.1950.x","article-title":"No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis.","volume":"34","author":"Nivenius","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"R20-17-20210204","first-page":"3036","article-title":". Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry.","volume":"40","author":"Leonardi","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-17-20210204","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00417-006-0285-7","article-title":". Th1- and Th2-type cytokines in chronic ocular allergy.","volume":"244","author":"Leonardi","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R22-17-20210204","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF00918743","article-title":". An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro.","volume":"6","author":"Nelson","year":"1986","journal-title":"J Clin Immunol"},{"key":"R23-17-20210204","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9394(14)73261-1","article-title":". Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis.","volume":"108","author":"Trocme","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"R24-17-20210204","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1357-4310(99)01635-4","article-title":"Eotaxin and eosinophil recruitment: implications for human disease.","volume":"6","author":"Rankin","year":"2000","journal-title":"Mol Med Today"},{"key":"R25-17-20210204","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0091-6749(98)70023-5","article-title":". Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases.","volume":"102","author":"Hingorani","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R26-17-20210204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2222.2000.00699.x","article-title":". Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis.","volume":"30","author":"Uchio","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"R27-17-20210204","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0091-6749(99)70206-X","article-title":". Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage.","volume":"103","author":"Fukagawa","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"R28-17-20210204","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1398-9995.2008.01858.x","article-title":". Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients.","volume":"64","author":"Leonardi","year":"2009","journal-title":"Allergy"},{"key":"R29-17-20210204","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/exer.1998.0499","article-title":". Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis.","volume":"67","author":"Leonardi","year":"1998","journal-title":"Exp Eye Res"},{"key":"R30-17-20210204","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":". Interleukin 17-producing CD4 effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"R31-17-20210204","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2249.2001.01602.x","article-title":"Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma.","volume":"125","author":"Wong","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"R32-17-20210204","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2567.2009.03114.x","article-title":"Th9 and allergic disease.","volume":"127","author":"Soroosh","year":"2009","journal-title":"Immunology"},{"key":"R34-17-20210204","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00003226-199311000-00008","article-title":". Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjogrens syndrome.","volume":"12","author":"Power","year":"1993","journal-title":"Cornea"},{"key":"R35-17-20210204","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-9394(89)90216-X","article-title":"Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis.","volume":"107","author":"Holland","year":"1989","journal-title":"Am J Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e31828ffdf8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T15:35:24Z","timestamp":1621870524000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201308000-00017"}},"subtitle":["The Effect of Topical 0.05% Cyclosporine A Therapy"],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31828ffdf8","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}